Immunology Virtual Partnering: 9-12 March, 2021
Autoimmune and Inflammatory Disease
During four days of face-to-face online meetings, leading researchers, top biotechs and biopharmaceutical companies will meet, network and partner to accelerate immunology pipelines and bring new treatment options to patients worldwide.
About this conference
Find the best early-stage biotechs
Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches have already been developed to curb the detrimental effects of autoimmune diseases, and the market continues to flourish. In fact, by 2025 this market is estimated to exceed a global value of $150 billion.
At Inova, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO), in partnership with Evaluate, are organizing this Immunology Virtual Partnering Event. Through online one-to-one meetings taking place 9-12 March, researchers, biotechs and biopharmaceutical companies will discuss the latest research from immunology congresses, pitch ideas and partner to prioritize the most promising research efforts.
This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide.
What is a virtual Partnering Event?
It’s a conference of virtual face-to-face meetings. All meetings are online instead of at a physical location.
Increase your company visibility during the event
Free Company Presentations
If you are an attending biotech, biopharma, medtech or digital health company, you benefit from free visibility with a company presentation (max. 6 minutes video or PDF slideshow).
Submit a presentationWho will attend?
The Immunology Virtual Partnering Event is open to any organization that provides product, knowledge or technologies that can help advance the immunology pipeline. Therapeutic areas like rheumatology, dermatology, and gastroenterology are expected to be particular areas of focus as is research aimed at tailoring treatments to complement the heterogenous pathophysiologic mechanisms to each patient or anticipating and addressing primary nonresponse and loss of response to current or new therapies.
Pharma & Biotech
Academia
Medical Research
Services
Clinical Trials
Diagnostic & Biomarkers
Carrier Systems & Formulation
Financing
The Virtual Partnering Event will bring these stakeholders together to pursue:
Potential R&D collaborations
Early stage discovery collaboration
Drug repurposing
Biological markers and diagnostic tests
Adjuvants, carrier systems, and formulation technologies
Tools for research projects
Animal and in-silico models
Funding and investors
Partners for clinical trials
“ALLERO is coming to Immunology Virtual Partnering to present our novel SOMIT platform technology for antigen specific immunotherapy of autoimmune and allergic disorders. The targeted one-on-one meetings specifically focused on Immunology will allow us to identify the best partners for this project.”
Timeline
Registration for the Immunology Virtual Partnering event opens on 18 January. Then, our partnering platform, One-on-One Partnering, will open on 15 February so that participants will have a little over 4 weeks to make connections and request online meetings. On 9 March the virtual partnering starts with online scheduled meetings for four days through 12 March.
18 January 2021
Registration opens
Registration for the Virtual
Partnering Event starts.
15 February 2021
Platform is open
Participants can begin
sending meeting requests.
9 - 12 March 2021
Virtual Conference
Scheduled meetings will
take place online.
About the Virtual Partnering Platform
This event will leverage Inova and BIO's matchmaking platform, One-on-One Partnering™, that has been at the heart of major international biopharmaceutical conventions since 2015. It’s the leading partnering system that facilitates thousands of face-to-face meetings at dozens of biopharma conferences worldwide including the BIO International Convention, BIO Digital and BIO Asia. For instance, in the weeks before the BIO International Convention, 4,000 biopharma companies connect online, list their technologies and capabilities, and request meetings with potential partners. By the time the Convention opens thousands of relevant meetings are scheduled – almost 50,000 at BIO Convention 2019 alone.
